Crow Point Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-44,565
Closed -$76K 295
2017
Q3
$76K Sell
44,565
-52,971
-54% -$90.3K 0.01% 195
2017
Q2
$200K Buy
+97,536
New +$200K 0.03% 128